Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety.

Blum K, Lewandrowski APL, Sharafshah A, Pinhasov A, Mohankumar K, Gold MS, Fuehrlein B, Elman I, Dennen C, Thanos PK, Bowirrat A, Baron D, Modestino EJ, Jafari N, Zeine F, Sunder K, Makale MT, Lorio MP, Khalsa J, Schmidt SL, Fiorelli RKA, Weinstein A, Lindenau M, Lewandrowski KU, Alves ÓL, Mahajan S, Mahajan Y, Badgaiyan RD

Open source

DOI: 10.2174/0113892010431102260107110422
Published: 2026 Mar 9
Container: Current pharmaceutical biotechnology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2174/0113892010431102260107110422,
  title = {Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety.},
  author = {Blum K and Lewandrowski APL and Sharafshah A and Pinhasov A and Mohankumar K and Gold MS and Fuehrlein B and Elman I and Dennen C and Thanos PK and Bowirrat A and Baron D and Modestino EJ and Jafari N and Zeine F and Sunder K and Makale MT and Lorio MP and Khalsa J and Schmidt SL and Fiorelli RKA and Weinstein A and Lindenau M and Lewandrowski KU and Alves ÓL and Mahajan S and Mahajan Y and Badgaiyan RD},
  year = {2026},
  journal = {Current pharmaceutical biotechnology},
  doi = {10.2174/0113892010431102260107110422},
  url = {https://doi.org/10.2174/0113892010431102260107110422}
}

RIS

TY  - JOUR
TI  - Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety.
AU  - Blum K
AU  - Lewandrowski APL
AU  - Sharafshah A
AU  - Pinhasov A
AU  - Mohankumar K
AU  - Gold MS
AU  - Fuehrlein B
AU  - Elman I
AU  - Dennen C
AU  - Thanos PK
AU  - Bowirrat A
AU  - Baron D
AU  - Modestino EJ
AU  - Jafari N
AU  - Zeine F
AU  - Sunder K
AU  - Makale MT
AU  - Lorio MP
AU  - Khalsa J
AU  - Schmidt SL
AU  - Fiorelli RKA
AU  - Weinstein A
AU  - Lindenau M
AU  - Lewandrowski KU
AU  - Alves ÓL
AU  - Mahajan S
AU  - Mahajan Y
AU  - Badgaiyan RD
PY  - 2026
JO  - Current pharmaceutical biotechnology
DO  - 10.2174/0113892010431102260107110422
UR  - https://doi.org/10.2174/0113892010431102260107110422
ER  -

APA

K, B., APL, L., A, S., A, P., K, M., MS, G., B, F., I, E., C, D., PK, T., A, B., D, B., EJ, M., N, J., F, Z., K, S., MT, M., MP, L., J, K., SL, S., RKA, F., A, W., M, L., KU, L., ÓL, A., S, M., Y, M., & RD, B. (2026). Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety.. Current pharmaceutical biotechnology. https://doi.org/10.2174/0113892010431102260107110422

Source records

pubmed · retrieved 2026-09-26T09:46:33.122Z